SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-215193
Filing Date
2012-05-07
Accepted
2012-05-07 16:38:01
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d338069d10q.htm 10-Q 613297
2 EX-31.1 d338069dex311.htm EX-31.1 9799
3 EX-31.2 d338069dex312.htm EX-31.2 9816
4 EX-32.1 d338069dex321.htm EX-32.1 4974
  Complete submission text file 0001193125-12-215193.txt   2192512

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anx-20120331.xml EX-101.INS 221986
6 XBRL TAXONOMY EXTENSION SCHEMA anx-20120331.xsd EX-101.SCH 15207
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anx-20120331_cal.xml EX-101.CAL 46331
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE anx-20120331_lab.xml EX-101.LAB 120463
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anx-20120331_pre.xml EX-101.PRE 81815
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 12818325
SIC: 2834 Pharmaceutical Preparations